Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Prospect Therapeutics, Inc.'s GCS-100 Inhibited Blood Vessel Formation In A Variety Of Cancer Models
Joseph F. Finn, Jr., C.P.A. ("Finn"), announced today that there has been promising initial interest from pharma companies in the intellectual property of Prospect Therapeutics, Inc. ("Prospect").

Gefitinib Receives European Licence For The Treatment Of Lung Cancer For Patients With EGFR Activating Mutation Positive Tumours
AstraZeneca announced that it has received a licence by the European Medicines Agency (EMEA) for its oral targeted anti-cancer drug, gefitinib, for EGFR (epidermal growth factor receptor-tyrosine kinase) activating mutation positive patients with Non Small Cell Lung Cancer (NSCLC). NSCLC is the most common type of lung cancer and accounts for 80% of all lung cancer cases. [1] The licence means that for the first time, thousands [2] of patients undergoing first line treatment of NSCLC in the UK may benefit from a more effective, [3] oral alternative to doublet chemotherapy (UK standard of care) without many of the side effects associated with chemotherapy. [3]
News of the day
Lobbyists Elbow For Attention As Health Reform Votes Loom
The conservative message on health care is that President Obama"s revamp of the health care system in America will produce a costly government-run program that limits patient choice, The Associated Press reports.
Health Insurance

Statement By HANYS' President Daniel Sisto On The White House Health Reform Agreement With Hospitals

"Today"s White House health care reform announcement clearly demonstrates that hospitals are willing to make a tremendous sacrifice to help expand health care coverage to millions of Americans who desperately need and deserve better access to care. "However, these cuts will be very difficult to absorb. New York"s hospital margins are the second lowest in the nation, with most hospitals barely breaking even or losing money each year. "Therefore, it is essential that our sacrifice is not made in vain. Congress and the Obama Administration must ensure that they pass and implement a final reform plan that will deliver on the promise of universal coverage. The outcomes must match the rhetoric. "It is also imperative that other non-provider sectors of health care also make commensurate contributions. Every stakeholder must be part of the solution. As the American Hospital Association says, "Coverage for all, paid for by all." "We must see this effort through, for all Americans who rely on, and pay for, a health care system that is in dire need of meaningful reform." Healthcare Association of New York State (HANYS)


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009